Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological ± Interventional) in Patient with Atrial Fibrillation

Clinical trial NCT06759909 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06759909
Sponsor: Assiut University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Dapagliflozin (Forxiga)Atrial Fibrillation (AF)

Start date: 2025-01-03
Primary completion: 2026-12-22
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.